News

The company has announced this voluntary recall to the user level following the discovery of four leaking premix bags during an investigation conducted in response to a product

At the ChanTest headquarters in Cleveland, Ohio, the company has expanded its physical footprint by more than 50%. The laboratory expansion reflects the importance of providing high quality

Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located within the SNUH Clinical Trials Center. This enables Celerion and its clients access to

This patent provides protection until 2031, not including any patent term extension. The patent complements Synageva’s existing and planned global patent portfolio covering its LAL deficiency program, which

Xenetic, in collaboration with the Massachusetts Life Sciences Center (MLSC) and the Massachusetts Biotechnology Council (MassBio), will host a grand opening and ribbon cutting ceremony to celebrate the

Results were presented in two poster presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) meeting in Boston. The first poster, entitled Immune Function and Viral Load

OMS721 is the company’s lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system. In the trial,

Adasuve is administered through Alexza Pharmaceuticals’ Staccato single-use, hand held drug delivery technology system. The new drug-device combination product provides rapid systemic delivery by inhalation of a thermally-generated

Vaprisol was developed and registered by Astellas and was commercially launched in 2006 and it is one of two branded prescription products indicated for the treatment of hyponatremia.